4//SEC Filing
De Rosch Mark 4
Accession 0000899243-23-002436
CIK 0001501796other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:36 PM ET
Size
7.4 KB
Accession
0000899243-23-002436
Insider Transaction Report
Form 4
De Rosch Mark
Chief Operating Officer
Transactions
- Award
Common Stock
2023-01-19+42,250→ 58,635 total - Award
Stock Option (Right to Buy)
2023-01-19+65,000→ 65,000 totalExercise: $10.18Exp: 2033-01-18→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant.
- [F2]The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of January 19, 2023 with the remainder vesting thereafter pro-rata in 36 monthly installments.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001890320
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 6:36 PM ET
- Size
- 7.4 KB